Content area
Full text
United Kingdom - Vigabatrin (Sabril®) is an anti-epileptic indicated, in combination with other anti-epileptics, for the treatment of patients with resistant partial epilepsy (with or without secondary generalization) who have not responded to or who are intolerant of all other appropriate drug combinations. Vigabatrin is also indicated as monotherapy in the treatment of infantile spasms (West syndrome).
Researchers in Finland first raised concerns about a risk of movement disorders (including...